149 related articles for article (PubMed ID: 2946497)
1. Interleukin 2 production in HTLV-III/LAV infection: evidence of defective antigen-induced, but normal mitogen-induced IL-2 production.
Antonen J; Krohn K
Clin Exp Immunol; 1986 Sep; 65(3):489-96. PubMed ID: 2946497
[TBL] [Abstract][Full Text] [Related]
2. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
[TBL] [Abstract][Full Text] [Related]
3. Immunological findings associated with HTLV-III antibody positivity.
Antonen J
Ann Clin Res; 1985; 17(2):81-5. PubMed ID: 2994542
[TBL] [Abstract][Full Text] [Related]
4. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
[TBL] [Abstract][Full Text] [Related]
5. Immune functions in homosexual men with antibodies to HTLV-III in Finland.
Krohn K; Ranki A; Antonen J; Valle SL; Suni J; Vaheri A; Saxinger C; Gallo RC
Clin Exp Immunol; 1985 Apr; 60(1):17-24. PubMed ID: 2988832
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
7. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
Margolick JB; Volkman DJ; Folks TM; Fauci AS
J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological findings in HTLV-III infection.
Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.
Clerici M; Wynn TA; Berzofsky JA; Blatt SP; Hendrix CW; Sher A; Coffman RL; Shearer GM
J Clin Invest; 1994 Feb; 93(2):768-75. PubMed ID: 8113410
[TBL] [Abstract][Full Text] [Related]
10. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
11. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.
Lane HC; Depper JM; Greene WC; Whalen G; Waldmann TA; Fauci AS
N Engl J Med; 1985 Jul; 313(2):79-84. PubMed ID: 2582258
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of interleukin 2 receptor expression associated with decreased antigen-induced lymphocyte proliferation in patients with AIDS and related disorders.
Prince HE; John JK
Clin Exp Immunol; 1987 Jan; 67(1):59-65. PubMed ID: 2957130
[TBL] [Abstract][Full Text] [Related]
13. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH
Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253
[TBL] [Abstract][Full Text] [Related]
14. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
Folks T; Kelly J; Benn S; Kinter A; Justement J; Gold J; Redfield R; Sell KW; Fauci AS
J Immunol; 1986 Jun; 136(11):4049-53. PubMed ID: 2422271
[TBL] [Abstract][Full Text] [Related]
16. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
Kajiyama Y; Umezu-Goto M; Kobayashi N; Takahashi K; Fukuchi Y; Mori A
Int Arch Allergy Immunol; 2007; 143 Suppl 1():71-5. PubMed ID: 17541281
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
[TBL] [Abstract][Full Text] [Related]
18. Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes.
Prince HE; Kermani-Arab V; Fahey JL
J Immunol; 1984 Sep; 133(3):1313-7. PubMed ID: 6235286
[TBL] [Abstract][Full Text] [Related]
19. Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells.
Swain SL; McKenzie DT; Weinberg AD; Hancock W
J Immunol; 1988 Nov; 141(10):3445-55. PubMed ID: 2972774
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 production and response by helper T-cell subsets in man.
Salmon M; Kitas GD; Gaston JS; Bacon PA
Immunology; 1988 Sep; 65(1):81-5. PubMed ID: 2972603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
